Biotron Limited
BITRF · OTC
6/30/2025 | 12/30/2024 | 6/30/2024 | 12/30/2023 | |
|---|---|---|---|---|
| Revenue | -$1 | $1,814 | $0 | $1,645 |
| % Growth | -100% | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $38 | $0 |
| Gross Profit | -$1 | $1,814 | -$38 | $1,645 |
| % Margin | 100% | 100% | – | 100% |
| R&D Expenses | $220 | $315 | $1,426 | $2,198 |
| G&A Expenses | $444 | $325 | $233 | $296 |
| SG&A Expenses | $751 | $763 | $649 | $747 |
| Sales & Mktg Exp. | $307 | $438 | $416 | $452 |
| Other Operating Expenses | $64 | $39 | $59 | $0 |
| Operating Expenses | $1,035 | $1,117 | $2,134 | $3,017 |
| Operating Income | -$1,036 | $697 | -$2,134 | -$1,372 |
| % Margin | 119,330% | 38.4% | – | -83.4% |
| Other Income/Exp. Net | $21 | -$0 | $21 | $48 |
| Pre-Tax Income | -$1,015 | $697 | -$2,113 | -$1,324 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,015 | $697 | -$2,113 | -$1,324 |
| % Margin | 116,958.5% | 38.4% | – | -80.5% |
| EPS | -0.001 | 0.001 | -0.002 | -0.001 |
| % Growth | -225% | 133.3% | -71.4% | – |
| EPS Diluted | -0.001 | 0.001 | -0.002 | -0.001 |
| Weighted Avg Shares Out | 1,096,328 | 998,037 | 902,869 | 903,008 |
| Weighted Avg Shares Out Dil | 1,096,139 | 991,923 | 902,275 | 902,065 |
| Supplemental Information | – | – | – | – |
| Interest Income | $21 | $0 | $44 | $48 |
| Interest Expense | $0 | $0 | $1 | $0 |
| Depreciation & Amortization | $4 | $7 | $1 | $22 |
| EBITDA | -$1,032 | $704 | -$2,133 | -$1,350 |
| % Margin | 118,854.1% | 38.8% | – | -82.1% |